121 related articles for article (PubMed ID: 1352077)
1. c-myc mRNA expression in non-Hodgkin's lymphomas.
Fellbaum C; Radaszkiewicz T; Ruhri C; Pütz B; Lehmacher W; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):61-8. PubMed ID: 1352077
[TBL] [Abstract][Full Text] [Related]
2. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
[TBL] [Abstract][Full Text] [Related]
3. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
4. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
5. Activation of MYCN in a case of non-Hodgkin's lymphoma.
Finnegan MC; Hammond DW; Hancock BW; Goyns MH
Leuk Lymphoma; 1995 Aug; 18(5-6):511-4. PubMed ID: 8528061
[TBL] [Abstract][Full Text] [Related]
6. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of EBV, Bcl-2, p53, c-Myc and Rb in non-Hodgkin's lymphoma.
Song W; Liu MG; Zhang JB; Zhang JJ; Sun MM; Yu QK
Eur Rev Med Pharmacol Sci; 2016; 20(6):1093-7. PubMed ID: 27049262
[TBL] [Abstract][Full Text] [Related]
8. Expression of BIRC7 protein and mRNA in non-Hodgkin's lymphoma.
Wu H; Ma Y; Zhu Y; Shen Y; Gu C; Ye Z; Lin H
Leuk Lymphoma; 2006 Jun; 47(6):1110-6. PubMed ID: 16840203
[TBL] [Abstract][Full Text] [Related]
9. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
[TBL] [Abstract][Full Text] [Related]
10. Fine-needle aspiration of non-Hodgkin's lymphoma. Southern blot analysis for antigen receptor, bcl-2, and c-myc gene rearrangements.
Williams ME; Frierson HF; Tabbarah S; Ennis PS
Am J Clin Pathol; 1990 Jun; 93(6):754-9. PubMed ID: 2189291
[TBL] [Abstract][Full Text] [Related]
11. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.
Hernández S; Hernández L; Beà S; Cazorla M; Fernández PL; Nadal A; Muntané J; Mallofré C; Montserrat E; Cardesa A; Campo E
Cancer Res; 1998 Apr; 58(8):1762-7. PubMed ID: 9563496
[TBL] [Abstract][Full Text] [Related]
12. c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas.
Hernández L; Hernández S; Beà S; Pinyol M; Ferrer A; Bosch F; Nadal A; Fernández PL; Palacín A; Montserrat E; Campo E
Leukemia; 1999 Dec; 13(12):2087-93. PubMed ID: 10602433
[TBL] [Abstract][Full Text] [Related]
13. Growth fractions in canine non-Hodgkin's lymphomas as determined in situ by the expression of the Ki-67 antigen.
Fournel-Fleury C; Magnol JP; Chabanne L; Ghernati I; Marchal T; Bonnefond C; Bryon PA; Felman P
J Comp Pathol; 1997 Jul; 117(1):61-72. PubMed ID: 9263844
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non-Hodgkin's lymphomas.
Schmitt F; Tani E; Tribukait B; Skoog L
Cytopathology; 1999 Apr; 10(2):87-96. PubMed ID: 10211614
[TBL] [Abstract][Full Text] [Related]
15. Proliferation in non-Hodgkin's lymphomas as determined by immunohistochemical double staining for Ki-67.
Tominaga K; Yamaguchi Y; Nozawa Y; Abe M; Wakasa H
Hematol Oncol; 1992; 10(3-4):163-9. PubMed ID: 1398512
[TBL] [Abstract][Full Text] [Related]
16. Proliferation markers in non-Hodgkin's lymphoma. A comparative study between cytophotometric quantitation of Ki-67 and flow cytometric proliferation index on fine needle aspirates.
Katz RL; Wojcik EM; el-Naggar AK; Ordonez NG; Johnston DA
Anal Quant Cytol Histol; 1993 Jun; 15(3):179-86. PubMed ID: 8347257
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and proliferative activity of non-Hodgkin's lymphomas: comparison with expression of bcl-2, p53 and c-myc proteins.
Takano Y; Saegusa M; Ikenaga M; Okayasu I
Pathol Int; 1997; 47(2-3):90-4. PubMed ID: 9088026
[TBL] [Abstract][Full Text] [Related]
18. Growth fraction in non-Hodgkin's lymphomas and reactive lymphadenitis determined by Ki-67 monoclonal antibody in fine-needle aspirates.
Skoog L; Tani E; Svedmyr E; Johansson B
Diagn Cytopathol; 1995 May; 12(3):234-8; discussion 238-40. PubMed ID: 7621718
[TBL] [Abstract][Full Text] [Related]
19. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67.
Gerdes J; Dallenbach F; Lennert K; Lemke H; Stein H
Hematol Oncol; 1984; 2(4):365-71. PubMed ID: 6396192
[TBL] [Abstract][Full Text] [Related]
20. Correlation between histology and immunophenotype in a series of 322 cases of non-Hodgkin's lymphoma.
Smith JL; Jones DB; Bell AJ; Wright DH
Hematol Oncol; 1989; 7(1):37-48. PubMed ID: 2642457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
